Wilczynski SP, Pearlman L: Identification of HPV 16 early genes retained in cervical carcinoma. Virology 166:624-627, 1988.
Wilczynski SP, Walker J, Liao SY, Bergen S, et al: Adenocarcinoma of the cervix associated with human papillomaviruses. Cancer 62:1332-1336, 1988.
Wilczynski SP, Walker J, Bergen S, et al: Human papillomaviruses and cervical carcinomas: Histologic features associated with different viral types. Hum Pathol 19:697-704, 1988.
Bloss J, Wilczynski SP, Liao SY, et al: The use of molecular probes to distinguish new primary tumors from recurrent tumors in gynecologic malignancies. Am J Clin Pathol 94:432-434, 1990.
Srivatsan ES, Misra BC, Venugopalan M and Wilczynski SP. Loss of heterozygosity for the long arm of chromosome 11 in cervical cancer. Am J. Hum Genet. 49:868-877, 1991.
Bloss J, Liao SY, Wilczynski SP, et al: Clinical and Histological Features of Vulvar Carcinomas Analyzed for HPV Status. Hum Pathol 22:711-718, 1991.
Bohm S. Wilczynski SP, Pfister H, et al. The predominant mRNA class in HPV 16-infected genital neoplasias does not encode the E6 and E7 protein. Intl J Cancer 55: 791-798, 1993.
Wilczynski SP, Oft M, Cook N, et al. Human Papillomavirus Type 6 in Squamous Cell Carcinoma of the Bladder and Cervix. Human Pathol. 24:96-102, 1993.
Burger RA, Monk BJ, Anton-Culver H, Wilczynski SP, et al. HPV 18 DNA types is an independent predictor of poor survival among patients with cervical carcinoma treated with radical hysterectomy. J Nat Cancer Inst. 88:1361-1368, 1996.
Grassmann K, Wilczynski SP, Cook N, et al. HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchanges in the E6 and E7 proteins. Virology 223:185-197, 1996.
Paz PI, Cook N, Odom-Maryon T, Xie Y, Wilcyznski SP. Human Papillomaviruses in head and neck cancers: an association of HPV16 with squamous cell carcinomas of the Waldeyer’s tonsillar ring. Cancer:79:595-604, 1997.
Wilczynski SP, Lin BTY, Xie Y, et al. Detection of HPV DNA and oncoprotein over-expression are associated with distinct morphologic patterns of tonsillar squamous cell carcinoma. Am J Pathology, 152:145-156, 1998.
Yazaki P, Wilczynski SP, Shively JE, et al. Initial clinical experience evaluating Yttrium-90-Chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer. Clinical Can Res 5:3224s-3231s, 1999.
Muderspach L, Wilczynski SP, Roman L, et al. A phase I trial of a HPV peptide vaccine for women with high grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res 6:3406-3416,2000.
Wong JYC, Chu DZ, Yamauchi DM, Williams LE, Liu A, Wilczynski SP, et al. A Phase I radioimmunotherapy trial evaluating 90Yttrium labeled anti-CEA chimeric T84.66 in Patients with metastatic CEA-producing malignancies. Clinical Cancer Res. 6:3855-3863, 2000.
Keefe KA, Schell JA, Chapman C, Brewer C, Wilczynski SP, et al. Effects of beta-carotene on cervical intraepithelial neoplasia: six-month interim results of two year Phase II/III trial. Cancer Epidem. Biomark. Preven 10:1029-1035, 2001.
Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, Yang PK, Kang K, Motamedi D, Sawicki MP, Zhuang A, Jesudasan RA, Bengtsson U, Sun C, Roe BA, Stanbridge EJ, Wilczynski SP, Redpath JL. Localization of deletion to a 300Kb interval of Chromosome 11q13 in Cervical Cancer. Oncogene 21: 5631-5642, 2002.
Pfeifer, GP, Yoon, JH, Liu L, Tommasi S, Wilczynski SP, et al. Methylation of the RASSF1A gene in human cancers. Biol Chem 383:907-914, 2002.
Markman M, Liu PY, Wilczynski S, et al. Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group Trial. J Clin Oncol 21:2460-2465, 2003.
Wong JF, Shibata F, Wliiams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski SP, et al. A phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5 –flourouracil in patients with metastaticv coloreactal cancer. Clin Can Res. 9:5842-5852, 2003.
Juhasz A, Frankel P, Cheng C, Ribera H, Vishwanath R, Chiu A, Margolin K, Yen Y, Newman EM, Synold T, Wilczynski S, et al. Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: Comparason real-time reverse transcription-pcr utilizing DNA sequencer analysis of pcr products. J Clin Anal 17: 184-194, 2003.
Kirshner J, Hardy J, Wilczynski S, Shively JE. Cell-cell adhesion molecule CEACAM1 is expressed in breast and milk and associates with beta 1 integrin in 3D model of morphogenesis. J Molecular Histology 35:287-299, 2004.
Rothenberg ML, Liu PY, Wilczynski SP, et al. Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group Study. Gynecol Oncol. 95 (3):506-12, 2004.
Tommasi S, Dammann R, Liu L, Wilczynski, SP, et al. Rassfla knockout mice are susceptible to tumor Formation. Cancer Res 65:92-98, 2005.
Wilczynski SP, Chen YY, Chen W, Howell SB, et al. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFR-alpha and PDGFR-beta in ovarian cancer. Human Pathol 36:242-249, 2005.
Scudder SA, Liu PY, Wilczynski SP, et al. Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of Southwest Oncology Group. Gyn Oncol 96:610-615, 2005.
McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilev SA, Wong PT, Simpson JF, Wilczynski SP. Uterine effects of tamoxifen: a prospective study. Int J. Gynecol Cancer. 16(2):814-820, 2006.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.